XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Financial instruments and risk management - Contractual maturities of these financial liabilities (Details)

Financial instruments and risk management - Contractual maturities of these financial liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Financial instruments and risk management
Accounts payable and accrued liabilities	$ 283,428	$ 1,445,213
Lease liability	11,510	77,599
Total	294,938	1,522,812
Not later than three months
Financial instruments and risk management
Accounts payable and accrued liabilities	283,428	1,445,213
Lease liability	11,510	16,064
Total	$ 294,938	1,461,277
Later than three months and not later than one year
Financial instruments and risk management
Lease liability		50,026
Total		50,026
Later than one year and not later than three years
Financial instruments and risk management
Lease liability		11,509
Total		$ 11,509

- Definition

The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity’s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity’s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]

+ References + Details